MAXIS GBN

Highlights the health and wellbeing impacts business travel can have on individuals and provides recommendations of what employers can do to combat some of these impacts

Despite general caution about international travel and significant advances in online conferencing technology, business travel remains an integral part of corporate life. Business travel spend is forecast to reach $1.6 trillion by 20201, but what are the responsibilities of employers towards their frequent flyer employees who could potentially experience health problems as a result?

In the whitepaper Business Travel: Good for Business, Bad for Health? MAXIS GBN examines how far employers should extend their duty of care to employees in this arena and whether they should provide compensation to employees who give up personal time to travel overseas.

Download the report

1 Ipsos MORI, ‘International Travel: Risks and Reality: The New Normal for Business’, November 2016.